Outcomes and toxicity of oral Fosfestrol in metastatic castration-resistant prostate cancer-a real-world experience

CONCLUSION: We conclude that oral Fosfestrol is a cheap and effective agent in the armamentarium against metastatic CRPC and warrants further studies in a clinical trial setting.PMID:37799959 | PMC:PMC10550288 | DOI:10.3332/ecancer.2023.1589

Source: Ecancermedicalscience - October 6, 2023 Category: Cancer & Oncology Authors: R Nandini Devi V P Praveen Kumar Shenoy Irshad Ismail Manuprasad Avaronnan Source Type: research